178 related articles for article (PubMed ID: 23973733)
1. Meeting report: 26th International Conference on Antiviral Research.
Vere Hodge RA
Antiviral Res; 2013 Oct; 100(1):276-85. PubMed ID: 23973733
[TBL] [Abstract][Full Text] [Related]
2. Meeting report: 27th International conference on antiviral research, in Raleigh, NC, USA.
Vere Hodge RA
Antiviral Res; 2014 Nov; 111():143-53. PubMed ID: 25218950
[TBL] [Abstract][Full Text] [Related]
3. Meeting report: 28th International Conference on Antiviral Research in Rome, Italy.
Vere Hodge RA
Antiviral Res; 2015 Nov; 123():172-87. PubMed ID: 26431686
[TBL] [Abstract][Full Text] [Related]
4. Highlights of the 30th International Conference on Antiviral Research.
Andrei G; Carter K; Janeba Z; Sampath A; Schang LM; Tarbet EB; Vere Hodge RA; Bray M; Esté JA
Antiviral Res; 2017 Sep; 145():184-196. PubMed ID: 28774800
[TBL] [Abstract][Full Text] [Related]
5. Meeting report: 29th International Conference on Antiviral Research in La Jolla, CA, USA.
Vere Hodge RA
Antiviral Res; 2017 Jan; 137():23-40. PubMed ID: 27815125
[TBL] [Abstract][Full Text] [Related]
6. A 40-year journey in search of selective antiviral chemotherapy.
De Clercq E
Annu Rev Pharmacol Toxicol; 2011; 51():1-24. PubMed ID: 20809796
[TBL] [Abstract][Full Text] [Related]
7. Meeting report: 30th International Conference on Antiviral Research, in Atlanta, GA, USA.
Vere Hodge RA
Antivir Chem Chemother; 2018; 26():2040206618783924. PubMed ID: 29954186
[TBL] [Abstract][Full Text] [Related]
8. Scientific report: highlights of 24th ICAR, 8-11 May 2011, Sofia, Bulgaria.
Vere Hodge A
Antivir Chem Chemother; 2011 Oct; 22(2):75-85. PubMed ID: 21984687
[TBL] [Abstract][Full Text] [Related]
9. Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday.
Li G; Yue T; Zhang P; Gu W; Gao LJ; Tan L
Molecules; 2021 Feb; 26(4):. PubMed ID: 33572409
[TBL] [Abstract][Full Text] [Related]
10. Human viral diseases: what is next for antiviral drug discovery?
De Clercq E
Curr Opin Virol; 2012 Oct; 2(5):572-9. PubMed ID: 22846888
[TBL] [Abstract][Full Text] [Related]
11. The program of antiviral agents inhibits virus infection.
Ding YZ; Lv JL; Zhang ZW; Ma XY; Zhang J; Zhang YG
Arch Microbiol; 2018 Aug; 200(6):841-846. PubMed ID: 29846759
[TBL] [Abstract][Full Text] [Related]
12. Abstracts of the 19th International Conference on Antiviral Research (ICAR), San Juan, Puerto Rico, May 7-11, 2006.
Antiviral Res; 2006 May; 70(1):A26-89. PubMed ID: 16696114
[No Abstract] [Full Text] [Related]
13. Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.
De Clercq E
Biochem Pharmacol; 2007 Apr; 73(7):911-22. PubMed ID: 17045247
[TBL] [Abstract][Full Text] [Related]
14. Meeting report: 32nd International Conference on Antiviral Research.
Tramontano E; Tarbet B; Spengler JR; Seley-Radtke K; Meier C; Jordan R; Janeba Z; Gowen B; Gentry B; Esté JA; Bray M; Andrei G; Schang LM;
Antiviral Res; 2019 Sep; 169():104550. PubMed ID: 31302149
[TBL] [Abstract][Full Text] [Related]
15. Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art.
Hostetler KY
Antiviral Res; 2009 May; 82(2):A84-98. PubMed ID: 19425198
[TBL] [Abstract][Full Text] [Related]
16. A cutting-edge view on the current state of antiviral drug development.
De Clercq E
Med Res Rev; 2013 Nov; 33(6):1249-77. PubMed ID: 23495004
[TBL] [Abstract][Full Text] [Related]
17. International society for antiviral research - 23rd international conference.
Mason VL
IDrugs; 2010 Jun; 13(6):363-5. PubMed ID: 20506054
[TBL] [Abstract][Full Text] [Related]
18. Perspectives on antiviral drug development.
Wainberg MA
Antiviral Res; 2009 Jan; 81(1):1-5. PubMed ID: 18948140
[TBL] [Abstract][Full Text] [Related]
19. Comparison of antiviral resistance across acute and chronic viral infections.
Mason S; Devincenzo JP; Toovey S; Wu JZ; Whitley RJ
Antiviral Res; 2018 Oct; 158():103-112. PubMed ID: 30086337
[TBL] [Abstract][Full Text] [Related]
20. Editorial overview: Antiviral strategies: Antiviral drug design: creating new ideas against old and new bugs.
Naesens L; Zoulim F
Curr Opin Virol; 2017 Jun; 24():v-vii. PubMed ID: 28743435
[No Abstract] [Full Text] [Related]
[Next] [New Search]
